FA
MDT icon

Financial Advantage’s Medtronic MDT Stock Holding History

Financial Advantage’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.71M Sell
21,831
-13,964
-39% -$1.17M 2.63% 17
2023
Q2 		$3.15M Buy
35,795
+574
+2% +$49.4K 2.82% 15
2023
Q1 		$2.84M Buy
35,221
+1,132
+3% +$92.3K 2.58% 19
2022
Q4 		$2.65M Buy
+34,089
New +$2.76M 2.46% 20

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Financial Advantage's MDT Position: Q3 2023 in Review

Financial Advantage reduced its Medtronic (MDT) stake by 39% in Q3 2023, selling an estimated $1.17M and leaving 21,831 shares worth $1.71M. The position accounts for 2.63% of the portfolio, ranked #17.

Financial Advantage first reported a position in MDT in Q4 2022 and has held it in 4 quarters since. The position peaked at $3.15M in Q2 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Financial Advantage held 21,831 shares of Medtronic worth $1.71M as of Q3 2023.
  • Financial Advantage sold 13,964 Medtronic shares in Q3 2023, an estimated $1.17M.
  • Medtronic made up 2.63% of Financial Advantage's portfolio in Q3 2023, its #17 holding.
  • Financial Advantage first reported a position in Medtronic in Q4 2022 and has held it in 4 quarters since.
  • Financial Advantage's Medtronic position peaked at $3.15M in Q2 2023.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Financial Advantage's 13F filing for Q3 2023, filed 7 Nov 2023.